TYLORIX CREAM
Composition:Ciclopirox Olamine 1% w/w Cream
Use For:TYLORIX (Ciclopirox Olamine 1% w/w Cream) is a broad-spectrum antifungal medication used for the treatment of various fungal and yeast infections of the skin. It works by inhibiting the growth of fungi and dermatophytes by interfering with their cell membrane integrity and essential metabolic processes. TYLORIX is commonly prescribed for conditions such as athlete’s foot (tinea pedis), jock itch (tinea cruris), ringworm (tinea corporis), and seborrheic dermatitis. It may also be effective in treating candidiasis and fungal infections around nails and skin folds When applied to the affected area as directed, usually twice daily, it helps reduce symptoms like redness, itching, scaling, and discomfort, promoting faster skin recovery. Regular and complete course application is essential to prevent recurrence and ensure optimal results.
CEFUCARE-CV (Cefuroxime Axetil 500mg + Potassium Clavulanate 125mg Tablets)
🔹 Product Overview:
CEFUCARE-CV is a combination antibiotic tablet containing Cefuroxime Axetil 500mg and Potassium Clavulanate 125mg. This combination effectively treats a wide range of bacterial infections by utilizing the dual action of Cefuroxime Axetil, a second-generation cephalosporin antibiotic, and Potassium Clavulanate, a beta-lactamase inhibitor.
Cefuroxime Axetil works by inhibiting the growth of bacteria through interference with their cell wall synthesis, while Potassium Clavulanate prevents bacterial resistance by inhibiting the beta-lactamase enzymes that some bacteria produce to neutralize antibiotics. This combination is particularly effective against infections caused by penicillin-resistant bacteria.
CEFUCARE-CV is widely prescribed for treating infections such as respiratory infections, urinary tract infections, skin infections, and ear infections, ensuring broad-spectrum coverage and enhanced efficacy. Manufactured in WHO-GMP certified facilities, CEFUCARE-CV ensures high quality and dependable results in fighting bacterial infections.
🔹 Key Features:
Dual Action: Contains Cefuroxime Axetil 500mg and Potassium Clavulanate 125mg for enhanced antibacterial activity.
Broad-Spectrum Coverage: Effective against a wide variety of gram-positive and gram-negative bacteria.
Combats Resistant Infections: Clavulanate protects against beta-lactamase-producing bacteria, enhancing the effectiveness of Cefuroxime.
Effective in Treating Various Infections: Includes respiratory, urinary, skin, and ear infections.
Quality-Assured: Manufactured in ISO and WHO-GMP certified facilities.
Available for PCD Pharma Franchise and Third-Party Manufacturing.
🔹 Benefits:
Highly Effective for Bacterial Infections: Treats a broad spectrum of bacterial infections, including pneumonia, bronchitis, and UTIs.
Prevents Antibiotic Resistance: The Clavulanate component enhances the activity of Cefuroxime by protecting it from beta-lactamase-producing bacteria.
Convenient Dosing: Once or twice daily dosing helps with patient compliance.
Well-Tolerated: Safe for use in most patients when prescribed appropriately.
🔹 How to Use:
Dosage: Take 1 tablet of CEFUCARE-CV twice daily or as directed by your physician.
Administration: Swallow the tablet whole with a glass of water, preferably with food to reduce stomach upset.
Timing: Take at the same time each day for consistent therapeutic effects.
Precautions:
Do not take if you are allergic to cephalosporins or penicillin.
Complete the full course of therapy as prescribed, even if you feel better, to ensure complete eradication of the infection.
Consult your healthcare provider if you have a history of kidney disease, liver disease, or gastrointestinal disorders.
🔹 For PCD Pharma Franchise:
We offer CEFUCARE-CV as part of our premium anti-infective range. Promotional support includes product samples, MR bags, visual aids, and monopoly distribution rights for eligible franchise partners.
🔹 For Third-Party Manufacturing:
CEFUCARE-CV is available for third-party manufacturing with customization options for brand name, packaging, and design. We ensure regulatory compliance, bulk production capabilities, and on-time delivery for both domestic and international markets.
KEYWORDS
Cefuroxime Axetil 500mg tablets, Potassium Clavulanate 125mg supplier, beta-lactamase inhibitor tablets, Cefuroxime Clavulanate tablets for infections, antibiotic tablets for bacterial infections, Cefuroxime Axetil 500mg Clavulanate tablets, Cefuroxime Clavulanate for respiratory infections, urinary tract infection treatment, Cefuroxime for pneumonia, beta-lactamase-resistant antibiotic, third-party manufacturing for antibiotics, PCD franchise for antibiotics, Potassium Clavulanate tablets manufacturer, Cefuroxime Axetil 500mg for skin infections, Clavulanate for bacterial resistance, PCD franchise for Cefuroxime, WHO-GMP certified antibiotic manufacturer, Potassium Clavulanate for ear infections, third-party antibiotic manufacturing India, Cefuroxime tablets for bacterial infections, antibiotic PCD company, anti-infective tablet franchise, Clavulanate combination antibiotic tablets, Clavulanate for bronchitis treatment, Cefuroxime for UTI treatment, beta-lactamase-resistant antibiotic for clinics, Cefuroxime for treating respiratory tract infections, Cefuroxime Clavulanate for skin and soft tissue infections, antibiotic tablets for bacterial pneumonia, Clavulanate as beta-lactamase inhibitor, anti-infective pharma franchise India, Cefuroxime for post-operative infections, Clavulanate for preventing bacterial resistance, Potassium Clavulanate for bacterial infections, Clavulanate and Cefuroxime for treating infections, Cefuroxime Axetil PCD pharma, third-party contract manufacturing for antibiotics, best antibiotic tablets for PCD franchise, WHO-GMP antibiotic manufacturers, Cefuroxime Clavulanate PCD company, Clavulanate tablets for treating ear infections, anti-infective antibiotic franchise companies, Cefuroxime tablets for bacterial pneumonia treatment, Clavulanate antibiotic suppliers India, Clavulanate combination tablets for doctors, Cefuroxime Axetil for chronic bacterial infections, third-party manufacturing for Clavulanate tablets, Cefuroxime for treating sinus infections, anti-infective tablet suppliers India, Cefuroxime Clavulanate tablets for treating throat infections, Clavulanate tablets for eye infections, beta-lactamase resistant antibiotics suppliers, PCD pharma antibiotic company India, Cefuroxime Clavulanate for treating sepsis, third-party manufacturing antibiotics, anti-infective tablets contract manufacturing, Potassium Clavulanate combination tablets suppliers, PCD franchise for anti-infective products, antibiotic tablets for third-party manufacturing, WHO approved Clavulanate antibiotic manufacturers, Clavulanate for treating dental infections, Clavulanate and Cefuroxime for mixed infections, Potassium Clavulanate combination PCD company, Clavulanate for fighting bacterial resistance, Cefuroxime for acute respiratory tract infections, antibiotic tablets PCD franchise distributor, Clavulanate for treating chronic infections, Cefuroxime tablets for infection prevention, Potassium Clavulanate for preventing bacterial growth, Cefuroxime Clavulanate for resistant infections, Clavulanate antibiotic for hospitalized patients, PCD companies for Clavulanate antibiotics, Cefuroxime Axetil Clavulanate for treatment of infections, effective antibiotics for PCD companies, Potassium Clavulanate as adjunct for antibiotic therapy, Clavulanate and Cefuroxime for treating wound infections, Cefuroxime for chronic UTI treatment, beta-lactamase inhibitor tablets for PCD, Clavulanate antibiotic supplier, Cefuroxime Axetil combination antibiotic tablets, antibiotic tablets for resistant bacteria, Clavulanate Cefuroxime for treating fever, Clavulanate antibiotic for treating sepsis, Potassium Clavulanate for treating chest infections, Cefuroxime Axetil for soft tissue infections, Potassium Clavulanate for respiratory tract infections, Cefuroxime Clavulanate for treating lower respiratory infections, Clavulanate antibiotic tablets for PCD franchise, Cefuroxime for preventing hospital-acquired infections, Potassium Clavulanate for chronic bacterial infections, Clavulanate for treating pneumonia, Cefuroxime and Clavulanate for treating infections, Clavulanate for infections caused by penicillin-resistant bacteria, Cefuroxime for systemic infections, Clavulanate for controlling bacterial growth, PCD antibiotic tablets India, anti-infective antibiotics for franchise, Cefuroxime Clavulanate tablets for sepsis management, Clavulanate for treating bacterial eye infections, Cefuroxime for respiratory system infections, Clavulanate as an adjunct to antibiotics, Potassium Clavulanate for multi-drug-resistant infections, Cefuroxime for reducing bacterial load, Clavulanate as beta-lactamase inhibitor in PCD company, Clavulanate and Cefuroxime for postoperative infection prevention, Clavulanate antibiotic PCD pharma, Potassium Clavulanate and Cefuroxime for treating systemic infections, Cefuroxime Clavulanate for chronic bronchitis, Clavulanate for lowering antibiotic resistance, Cefuroxime for treating acute bacterial infections, Clavulanate Cefuroxime for preventing surgical infections, Potassium Clavulanate in combination with Cefuroxime for resistant infections, third-party manufacturing for beta-lactamase inhibitors, Cefuroxime for treating fever and infections, Cefuroxime and Clavulanate for treating gastrointestinal infections.Cefuroxime Clavulanate tablets for infections, Cefuroxime Axetil for respiratory infections, Potassium Clavulanate in antibiotic therapy, Cefuroxime for treating bacterial pneumonia, Clavulanate for treating beta-lactamase resistant bacteria, Cefuroxime Axetil for treating UTI, Potassium Clavulanate for preventing bacterial resistance, Cefuroxime Axetil tablets for chronic infections, beta-lactamase inhibitor antibiotics, Cefuroxime for skin and soft tissue infections, Clavulanate for treating sinusitis, Cefuroxime Axetil for bronchitis, third-party manufacturing of Cefuroxime Clavulanate tablets, Potassium Clavulanate for treating ear infections, antibiotic tablets for PCD franchise, Cefuroxime Axetil and Clavulanate combination therapy, Clavulanate antibiotic for hospital infections, Cefuroxime for treating bacterial eye infections, Potassium Clavulanate combination tablets manufacturer, Clavulanate antibiotic PCD pharma franchise, Cefuroxime Clavulanate for treating tonsillitis, Potassium Clavulanate combination tablets suppliers, antibiotic therapy for bacterial infections, Cefuroxime for reducing infection recurrence, Clavulanate Cefuroxime for treating acute bacterial infections, Potassium Clavulanate as adjunct for Cefuroxime therapy, Cefuroxime for treating upper respiratory infections, Clavulanate for preventing antibiotic resistance, third-party manufacturing for antibiotics, Potassium Clavulanate for treating infections in immune-compromised patients, Clavulanate antibiotic tablets for third-party manufacturing, PCD pharma for Cefuroxime Clavulanate, Clavulanate for treating endocarditis, Cefuroxime Clavulanate tablets for treating sepsis, Clavulanate for treating gonorrhea infections, Cefuroxime for treating bacterial infections in children, Cefuroxime Axetil PCD pharma, Potassium Clavulanate for treating bronchial infections, Cefuroxime for acute lower respiratory tract infections, Potassium Clavulanate for soft tissue infections, Clavulanate antibiotics for resistant strains, Cefuroxime and Clavulanate for postoperative infection prevention, third-party antibiotic manufacturing, Cefuroxime for chronic sinusitis, Potassium Clavulanate as beta-lactamase inhibitor in antibiotics, Cefuroxime for treating pelvic infections, Clavulanate for treating bacterial prostatitis, Cefuroxime Axetil and Potassium Clavulanate for treating complex infections, PCD company for antibiotic franchise, Cefuroxime and Clavulanate combination for pneumonia treatment, third-party manufacturing of broad-spectrum antibiotics, Clavulanate and Cefuroxime for treating bacterial infections, Cefuroxime for treating endocarditis and sepsis, Clavulanate antibiotic for urinary infections, Cefuroxime for bacterial respiratory tract infections, PCD pharma company for Clavulanate antibiotics, Cefuroxime Clavulanate for acute infections, Clavulanate in infection management for PCD pharma, Cefuroxime Axetil for treating pneumonia in children, Potassium Clavulanate for chronic bacterial infections, Clavulanate Cefuroxime for treating mixed bacterial infections, Cefuroxime for treating otitis media, Cefuroxime and Clavulanate for soft tissue infections, PCD pharmaceutical products for antibiotic therapy, Potassium Clavulanate in treating mixed infections, Cefuroxime Clavulanate for treating ear, nose, and throat infections, Clavulanate and Cefuroxime for treating bacterial infections, third-party antibiotic manufacturer in India, Cefuroxime for preventing infections after surgery, Cefuroxime for skin infection treatment, Clavulanate for reducing bacterial resistance, Cefuroxime for bacterial sinusitis, Potassium Clavulanate for postoperative bacterial infections, Clavulanate for preventing bacterial growth in infections, Cefuroxime Clavulanate for treating soft tissue infections, Cefuroxime for treating pharyngitis, PCD company for Cefuroxime antibiotics, Cefuroxime and Clavulanate for effective bacterial infection treatment, Cefuroxime for UTI treatment, Cefuroxime Axetil for upper respiratory tract infections, Clavulanate for managing bacterial resistance in PCD pharma, Cefuroxime Axetil tablets for systemic infections, Clavulanate antibiotic for treatment of chronic infections, Cefuroxime Clavulanate for treating bacterial conjunctivitis, Clavulanate for controlling bacterial infections in the skin, Potassium Clavulanate and Cefuroxime for pediatric infections, Cefuroxime for treating meningitis, Clavulanate as part of multi-drug antibiotic treatment, Cefuroxime Axetil and Clavulanate for bacterial wound infections, Cefuroxime for reducing post-operative infections, Potassium Clavulanate for bacterial pneumonia treatment, Cefuroxime for treating recurrent UTI, Clavulanate and Cefuroxime for managing multiple infections, Cefuroxime for treating bacterial vaginosis, Clavulanate antibiotic for multi-drug-resistant infections, Cefuroxime for chronic bronchitis, Cefuroxime for treating bacterial infections in elderly patients, Clavulanate for treating chronic eye infections, Cefuroxime for controlling bacterial infections in immunocompromised patients, Potassium Clavulanate for reducing the incidence of resistant infections, Cefuroxime Axetil tablets for pneumonia, third-party manufacturing antibiotic for export, Cefuroxime for treating bacterial skin infections, Cefuroxime and Clavulanate for managing complex infections, PCD antibiotic distributor India, Cefuroxime Clavulanate tablets for ear infections, Cefuroxime and Clavulanate for treating sore throat infections, Clavulanate for improving antibiotic efficacy, Clavulanate and Cefuroxime for managing abscesses, Cefuroxime for bacterial eye infections in children, Potassium Clavulanate for treating post-surgical infections, Clavulanate for treating infected wounds, Potassium Clavulanate combination for treating soft tissue infections, Cefuroxime for managing bacterial infections in diabetic patients, Clavulanate for controlling antibiotic-resistant infections, Cefuroxime Clavulanate for managing respiratory infections in elderly, Cefuroxime for controlling bacterial infection outbreaks, Clavulanate in managing severe infections, Cefuroxime for multi-drug-resistant infections, Clavulanate as an adjunct in managing mixed infections, Cefuroxime for managing pediatric bacterial infections, Potassium Clavulanate for treating recurrent respiratory infections, Clavulanate for chronic infection prevention, Cefuroxime for preventing bacterial resistance in hospital settings, Potassium Clavulanate for controlling infection in compromised immune systems, Cefuroxime for managing post-trauma infections, Cefuroxime for controlling bacterial infections in cystic fibrosis patients, Cefuroxime for treating severe bacterial infections in adults, Cefuroxime and Clavulanate for pediatric infection treatment, Potassium Clavulanate for treating complex bacterial infections, Cefuroxime for preventing postoperative infection recurrence, Cefuroxime for reducing complications in infection management, Cefuroxime and Clavulanate combination tablets, third-party contract manufacturing for Cefuroxime Clavulanate tablets, Cefuroxime and Clavulanate for managing long-term infections, Clavulanate as an important component in multi-drug antibiotics, Cefuroxime and Clavulanate for treating abscesses and infections, Potassium Clavulanate for improving antibiotic resistance management, Clavulanate and Cefuroxime for treating bone infections, Cefuroxime for post-surgical infection management, Potassium Clavulanate and Cefuroxime for treating infected wounds in hospitals, Cefuroxime for managing severe upper respiratory infections, Clavulanate for enhancing the effectiveness of Cefuroxime in hospital infections, Cefuroxime Axetil and Clavulanate for controlling hospital-acquired infections.